Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial.

Motohiro TamiyaAkihiro TamiyaTakako InoueMadoka KimuraKei KunimasaKenji NakahamaYoshihiko TaniguchiTakayuki ShiroyamaShun-Ichi IsaKazumi NishinoToru KumagaiHidekazu SuzukiTomonori HirashimaShinji AtagiFumio Imamura

Published in: PloS one (2018)

Liver and lung metastases and a poor performance status are independent predictors of nivolumab efficacy in patients with advanced non-small cell lung cancer.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
squamous cell carcinoma
small cell lung cancer
clinical trial
tyrosine kinase
phase iii
cross sectional
double blind
open label